Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting
Phase 2
Completed
- Conditions
- Tibia Plateau Fractures
- Interventions
- Drug: I-0401 (a new bone graft substitute)
- First Posted Date
- 2006-12-11
- Last Posted Date
- 2012-03-16
- Lead Sponsor
- Kuros Biosurgery AG
- Target Recruit Count
- 208
- Registration Number
- NCT00409799
- Locations
- 🇩🇪
Charite, Campus Virchow Klinikum (03), Berlin, Germany
🇨🇭CHUV Lausanne (02), Lausanne, Switzerland
🇮🇹Istituti Ortopedici Rizzoli (13), Bologna, Italy
© Copyright 2025. All Rights Reserved by MedPath